Literature DB >> 24051121

Down-regulation of CD5 expression on activated CD8+ T cells in familial hemophagocytic lymphohistiocytosis with perforin gene mutations.

Taizo Wada1, Yasuhisa Sakakibara, Ryosei Nishimura, Tomoko Toma, Yasuhisa Ueno, Seiki Horita, Taihei Tanaka, Masanori Nishi, Keisuke Kato, Takahiro Yasumi, Osamu Ohara, Akihiro Yachie.   

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is characterized by uncontrolled activation of T cells and macrophages with overproduction of cytokines. Familial HLH type 2 (FHL2) is the most common form of primary HLH and is caused by mutations in PRF1. We have recently described a significant increase in the subpopulation of CD8(+) T cells with clonal expansion and CD5 down-regulation in Epstein-Barr virus associated-HLH, which represented a valuable tool for its diagnosis. However, this unusual phenotype of CD8(+) T cells has not been investigated fully in patients with FHL2. We performed immunophenotypic analysis of peripheral blood and measured serum pro-inflammatory cytokines in five patients with FHL2. All patients showed significantly increased subpopulations of activated CD8(+) T cells with down-regulation of CD5, which were negligible among normal controls. Analysis of T-cell receptor Vβ repertoire suggested the reactive and oligoclonal expansion of these cells. The proportion of the subset declined after successful treatment concomitant with reduction in the serum levels of cytokines in all patients except one who continued to have a high proportion of the subset and died. These findings suggest that down-regulation of CD5 on activated CD8(+) T cells may serve as a useful marker of dysregulated T cell activation and proliferation in FHL2.
Copyright © 2013 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EBV; Epstein-Barr virus; FHL; HLA; HLH; IM; NK; PBMCs; PE; T-cell receptor; TCR; familial hemophagocytic lymphohistiocytosis; hemophagocytic lymphohistiocytosis; human leukocyte antigen; infectious mononucleosis; mAb; monoclonal antibody; natural killer; peripheral blood mononuclear cells; phycoerythrin

Mesh:

Substances:

Year:  2013        PMID: 24051121     DOI: 10.1016/j.humimm.2013.09.001

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  8 in total

1.  Exonal switch down-regulates the expression of CD5 on blasts of acute T cell leukaemia.

Authors:  A K Rai; A Singh; A Saxena; T Seth; V Raina; D K Mitra
Journal:  Clin Exp Immunol       Date:  2017-09-05       Impact factor: 4.330

2.  T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis.

Authors:  Vandana Chaturvedi; Rebecca A Marsh; Adi Zoref-Lorenz; Erika Owsley; Vijaya Chaturvedi; Trung C Nguyen; Jordana R Goldman; Michael M Henry; Jay N Greenberg; Stephan Ladisch; Michelle L Hermiston; Michael Jeng; Ahmed Naqvi; Carl E Allen; Hector R Wong; Michael B Jordan
Journal:  Blood       Date:  2021-04-29       Impact factor: 25.476

3.  First report on familial hemophagocytic lymphohistiocytosis with an abnormal immunophenotype and T cell monoclonality in Korea.

Authors:  Sang-Yong Shin; Kyunghoon Lee; Mi-Ae Jang; Seung-Tae Lee; Keon Hee Yoo; Hong Hoe Koo; Dae Shick Kim; Hee-Jin Kim; Sun-Hee Kim
Journal:  Ann Lab Med       Date:  2014-12-08       Impact factor: 3.464

4.  Cytologic Analysis of Epstein-Barr Virus-Associated T/Natural Killer-Cell Lymphoproliferative Diseases.

Authors:  Akihiro Yachie
Journal:  Front Pediatr       Date:  2018-11-16       Impact factor: 3.418

5.  Mechanism of tanshinones and phenolic acids from Danshen in the treatment of coronary heart disease based on co-expression network.

Authors:  Dongxue Wu; Mengqi Huo; Xi Chen; Yanling Zhang; Yanjiang Qiao
Journal:  BMC Complement Med Ther       Date:  2020-02-03

6.  RF1 Gene Mutation in Familial Hemophagocytic Lymphohistiocytosis 2: A Family Report and Literature Review.

Authors:  Yuan Shi; Zhidong Qiao; Xiaoduo Bi; Chenxin Zhang; Junxian Fu; Yuexin Jia; Guanglu Yang
Journal:  Pharmgenomics Pers Med       Date:  2021-12-16

7.  Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States.

Authors:  Lena F Schimke; Alexandre H C Marques; Gabriela Crispim Baiocchi; Caroline Aliane de Souza Prado; Dennyson Leandro M Fonseca; Paula Paccielli Freire; Desirée Rodrigues Plaça; Igor Salerno Filgueiras; Ranieri Coelho Salgado; Gabriel Jansen-Marques; Antonio Edson Rocha Oliveira; Jean Pierre Schatzmann Peron; Gustavo Cabral-Miranda; José Alexandre Marzagão Barbuto; Niels Olsen Saraiva Camara; Vera Lúcia Garcia Calich; Hans D Ochs; Antonio Condino-Neto; Katherine A Overmyer; Joshua J Coon; Joseph Balnis; Ariel Jaitovich; Jonas Schulte-Schrepping; Thomas Ulas; Joachim L Schultze; Helder I Nakaya; Igor Jurisica; Otávio Cabral-Marques
Journal:  Cells       Date:  2022-03-01       Impact factor: 7.666

8.  Clinical analysis of 42 cases of EBV-positive mature T/NK-cell neoplasms.

Authors:  Haiyan Yang; Gan Fu; Jia Liu; Zhenzhen Da; Xiaoye Cheng; Cong Chen; Yan Li; Bin Fu; Xiaolin Li
Journal:  Exp Ther Med       Date:  2017-06-01       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.